HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Lung Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care Selected Research
Lung Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care Research Topics
Disease
4
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2006 - 12/2005
3
Neoplasms (Cancer)
11/2006 - 12/2005
2
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
04/2007 - 02/2004
2
Malignant Mesothelioma
07/2006 - 07/2006
1
Thrombocytopenia (Thrombopenia)
04/2007
1
Anemia
04/2007
1
Diarrhea
04/2007
1
Febrile Neutropenia
11/2006
1
Disease Progression
05/2006
Drug/Important Bio-Agent (IBA)
4
Cisplatin (Platino)
FDA Link
Generic
04/2007 - 02/2004
2
Etoposide (VP 16)
FDA Link
Generic
04/2007 - 02/2004
2
Carboplatin (JM8)
FDA Link
Generic
04/2007 - 12/2005
2
Gefitinib (Iressa)
FDA Link
11/2006 - 05/2006
2
Docetaxel (Taxotere)
FDA Link
11/2006 - 12/2005
1
Topotecan (Hycamtin)
FDA Link
Generic
04/2007
1
Pemetrexed (MTA)
FDA Link
07/2006
1
ErbB Receptors (EGF Receptor)
IBA
05/2006
1
Erlotinib Hydrochloride (CP 358,774)
FDA Link
05/2006
1
Platinum
IBA
05/2006
1
Taxoids (Taxanes)
IBA
12/2005
1
taxane
IBA
12/2005
1
Gemcitabine
FDA Link
12/2005
1
Paclitaxel (Taxol)
FDA Link
Generic
12/2005
1
Vinorelbine (Navelbine)
FDA Link
Generic
12/2005
Therapy/Procedure
5
Drug Therapy (Chemotherapy)
04/2007 - 02/2004
4
Therapeutics
11/2006 - 12/2005
2
Radiotherapy
07/2006 - 02/2004
2
Combination Drug Therapy (Combination Chemotherapy)
12/2005 - 02/2004
1
Oral Administration
04/2007
1
Contraindications
12/2005
1
Duration of Therapy
02/2004